ПЭТ с18F-холином в диагностике глиальных опухолей головного мозга
Аннотация
Об авторах
Михаил Борисович ДолгушинРоссия
Акгуль Атаевна Оджарова
Россия
Павел Евгеньевич Тулин
Россия
Нина Борисовна Вихрова
Россия
Денис Ильич Невзоров
Россия
Михаил Александрович Меньков
Россия
Эмилия Андреевна Нечипай
Россия
Екатерина Алексеевна Кобякова
Россия
Али Хасьянович Бекяшев
Россия
Список литературы
1. Haacke E.M., Mittal S., Wu Z. et al. Susceptibility-Weighted Imaging: Technical Aspectsand Clinical Applications. Am. J. Neuroradiol. 2009; 30: 19-30.
2. Пронин И.Н., Туркин А.М., Долгушин М.Б. и др. Тканевая контрастность, обусловленная магнитной восприимчивостью: применение в нейрорентгенологии. Мед. виз. 2011; 1: 8-12.
3. Schaefer P., Roccatagliata L., Ledezma C. et al. First-pass quantitative CT perfusion identifies thresholds for salvageable penumbra in acute stroke patients treated with intraarterial therapy. Am. J. Neuroradiol. 2006; 27: 20-25.
4. Долгушин М.Б., Пронин И.Н., Фадеева Л.М., Корниенко В.Н. Метод КТ-перфузии в дифференциальной диагностике вторичного опухолевого поражения головного мозга. Мед. виз. 2007; 4: 100-106.
5. Пронин И.Н., Фадеева Л.М., Захарова Н.Е. и др. Перфузионная КТ: исследование мозговой гемодинамики в норме. Мед. виз. 2007; 3: 8-12.
6. Долгушин М.Б., Пронин И.Н. Перфузионная компьютерная томография в динамической оценке эффективности лучевой терапии при вторичном опухолевом поражении головного мозга. Вестн. РОНЦ им. Н.Н. Блохина РАМН. 2008; 4: 36-46.
7. Burtscher I.M., Skagerberg G., Geijer B. et al. Proton MR spectroscopy and preoperative diagnostic accuracy: An evaluation of intracranial mass lesions characterized by stereotactic biopsy findings. Am. J. Neuroradiol. 2000; 21: 84-93.
8. Подопригора А.Е., Пронин И.Н., Фадеева Л.М. Протонная магнитно-резонансная спектроскопия в диагностике опухолевых и неопухолевых поражений головного мозга. Вопр. нейрохир. 2000; 3: 7-20.
9. Ando K., Ishikura R., Nagami Y. et al. Usefulness of Cho/Cr ratio in proton MR spectroscopy for differentiating residual/recurrent glioma from non-neoplastic lesions. Nippon. Igaku Hoshasen Gakkai. 2004; 64: 121-126.
10. Hollingworth W., Medina L., Lenkinski R. et al. A systematic literature review of magnetic resonance spectroscopy (MRS) for the characterization of brain tumors. Am. J. Neuroradiol. 2006; 27; 7: 1404-1411.
11. Hara T., Kosaka N., Shinoura N. et al. PET imaging of brain tumor with [methyl-11C] choline. J. Nucl. Med. 1997; 38: 842-847.
12. Shinoura, N., Nishijima M., Hara T. et al. Brain tumors: detection with C-11 choline PET. Radiology. 1997; 202; 2: 497-503.
13. Langen K.J., Jarosch M., Muhlensiepen H. et al. Comparison of fluorotyrosinesand methionine uptake in F98 rat gliomas. Nucl. Med. Biol. 2003; 30: 501-508.
14. Kwee S.A., Ko J.P., Jiang C.S. et al. Solitary brain lesions enhancing at MR imaging: evaluation with fluorine 18 fluorocholine PET. Radiology. 2007; 244: 557-565.
15. Wyss M.T., Spaeth N., Biollaz G. et al. Uptake of 18F-Fluorocholine, 18F-FET, and 18F-FDG in C6 gliomas and correlation with 131I-SIP(L19), a marker of angiogenesis. J. Nucl. Med. 2007; 48; 4: 608-614.
16. Wester H.J., Herz M., Weber W. et al. Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging. J. Nucl. Med. 1999; 40: 205-212.
17. Gauthier S., Diksic M., Yamamoto L. et al. Positron emission tomography with [11C] choline in human subjects. Can. J. Neural. Sci. 1985; 12: 214.
18. Amane S.P., Honig M.A., Milner T.A. et al. Sites of acetylcholine synthesis and release associated with microvessels in cerebral cortex: ultrastructural and neurochemical studies. J. Cereb. Blood Flow Metab. 1987; 7: 5330.
19. Hamel E., Assumel-Lurdin C., Edvinsson L. et al. Neuronal versusendothelial origin of vasoactive acethylcholine in pial vessels. Brain Res. 1987; 420: 391-396.
20. Estrada C., Bready J., Berliner J., Cancilla P.A. Choline uptake by cerebral capillaryendothelial cells in culture. J. Neurochem. 1990; 54: 1467-1473.
21. Haubrich D.R., Wang P.F.L., Wedeking P.W. Distribution and metabolism of intravenously administered choline[methyl-3H] and synthesis in vivo of acetylcholine in various tissues of guinea pigs. J. Pharmacol. Exp.Ther. 1975; 193: 246-255.
22. DeGrado T.R., Baldwin S.W., Wang S. et al. Synthesis and evaluation of(18)F-labeled choline analogs as oncologic PET tracers. J. Nucl. Med. 2001; 42: 1805-1814.
23. Moore K.R., Harnsberger H.R., Shelton C., Davidson H.C. “Leave me alone” lesions of the petrous apex. Am. J. Neuroradiol. 1998; 19: 733-738.
24. Katz-Brull R., Degani H. Kinetics of choline transport and phosphorylationin human breast cancer cells NMR application of the zero transmethod. Anticancer Res. 1996; 16: 1375-1380.
25. Nakagami K., Uchida T., Ohwada S. et al. Increased choline kinaseactivity and elevated phosphocholine levels in human colon cancer. Jpn. J. Cancer Res. 1999; 90: 419-424.
26. Ramirez de Molina A., Rodriguez-Gonzalez A., Gutierrez R. et al. Overexpression of choline kinase is a frequent feature in human tumorderivedcell lines and in lung, prostate, and colorectal human cancers. Biochem. Biophys. Res. Commun. 2002; 296: 580-583.
27. Slack B.E., Richardson U., Nitsch R.M., Wurtman R.J. Dioctanoylglycerol stimulates accumulation of [methyl-'4C]choline and its incorporation into acetylcholine and phosphatidylcholine in a human cholinergic neuroblastoma cell line. Brain Res. 1972; 585: 169-176.
28. Yavin I. Regulation of phospholipid metabolism in differentiating cells from rat brain cerebral hemispheres in culture: patterns of acetylcholine, phosphocholine and cholinephosphoglycerides labeling from [C] cholin. J. Biol. 1976; 251: 1392-1397.
29. Galea E., Estrada C. Ouabaine-sensitive choline transport system in capillaries isolated from bovine brain. J. Neurochem. 1992; 59: 936-941.
30. Vanpouille C., Le Jeune N., Kryza D. et al. Influence of multidrug resistance on (18)F-FCH cellular uptake in a glioblastoma model. Eur. J. Nucl. Med. Mol. Imaging. 2009; 36 (8): 1256-1264.
31. Hara T., Kosaka N., Kishi H. PET imaging of prostate cancer using carbon-11-choline. J. Nucl. Med. 1998; 39: 990-995.
32. DeGrado T.R., Coleman R.E., Wang S. et al. Synthesis and evaluation of18F-labeled choline as an oncologic tracer for positron emission tomography: Initial findings in prostate cancer. Cancer Res. 2001; 61: 110-117.
33. Hara T., Kosaka N., Kishi H. Development of (18)F-fluoroethylcholine for cancer imaging with PET: Synthesis, biochemistry, and prostatecancer imaging. J. Nucl. Med. 2002; 43: 187-199.
34. Ohtani T., Kurihara H., Ishiuchi S. et al. Brain tumour imaging with carbon-11-choline: Comparison with FDG PET and gadolinium-enhanced MR imaging. Eur. J. Nucl. Med. 2001; 28: 1664-1670.
35. Provenzale J.M., McGraw P, Mhatre P et al. Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion weighted MR imaging and diffusion-tensor MR imaging. Radiology. 2004; 232: 451-460.
36. Goebell E., Paustenbach S., Vaeterlein O. et al. Low-grade and anaplastic gliomas: Differences in architecture evaluated with diffusion-tensor MR imaging. Radiology. 2006; 239: 217-222.
37. Tan H., Chen L., Guan Y., Lin X. Comparison of MRI, F-18 FDG, and 11C-choline PET/CT for their potentials in differentiating brain tumor recurrence from brain tumor necrosis following radiotherapy. Clin. Nucl. Med. 2011; 36 (11): 978-981.
Для цитирования:
Долгушин М.Б., Оджарова А.А., Тулин П.Е., Вихрова Н.Б., Невзоров Д.И., Меньков М.А., Нечипай Э.А., Кобякова Е.А., Бекяшев А.Х. ПЭТ с18F-холином в диагностике глиальных опухолей головного мозга. Медицинская визуализация. 2014;(3):73-83.
For citation:
Dolgushin M.B., Odzharova A.A., Tulin P.Y., Vikhrova N.B., Nevzorov D.I., Menkov M.A., Nechipai E.A., Kobyakova E.A., Bekyashev A.K. Use18F-choline PET in Cerebral Gliomas. Medical Visualization. 2014;(3):73-83. (In Russ.)